Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Potential of glyburide to reduce intracerebral edema in brain metastases.

Boggs DH, Simard JM, Steven A, Mehta MP.

Expert Rev Neurother. 2014 Apr;14(4):379-88. doi: 10.1586/14737175.2014.890891. Epub 2014 Feb 19. Review.

PMID:
24552576
2.

Glibenclamide for the treatment of ischemic and hemorrhagic stroke.

Caffes N, Kurland DB, Gerzanich V, Simard JM.

Int J Mol Sci. 2015 Mar 4;16(3):4973-84. doi: 10.3390/ijms16034973. Review.

3.

Glibenclamide for acute brain edema. Is the good news coming?

Welling LC, Welling MS, Teixeira MJ, Figueiredo EG.

World Neurosurg. 2015 Mar;83(3):281-2. doi: 10.1016/j.wneu.2015.01.003. Epub 2015 Jan 15. No abstract available.

PMID:
25598419
4.

Sulfonylurea receptor 1 contributes to the astrocyte swelling and brain edema in acute liver failure.

Jayakumar AR, Valdes V, Tong XY, Shamaladevi N, Gonzalez W, Norenberg MD.

Transl Stroke Res. 2014 Feb;5(1):28-37. doi: 10.1007/s12975-014-0328-z. Epub 2014 Jan 18.

5.

Inhibition of SUR1 decreases the vascular permeability of cerebral metastases.

Thompson EM, Pishko GL, Muldoon LL, Neuwelt EA.

Neoplasia. 2013 May;15(5):535-43.

6.

Glibenclamide in cerebral ischemia and stroke.

Simard JM, Sheth KN, Kimberly WT, Stern BJ, del Zoppo GJ, Jacobson S, Gerzanich V.

Neurocrit Care. 2014 Apr;20(2):319-33. doi: 10.1007/s12028-013-9923-1. Review.

7.

Novel approaches to the primary prevention of edema after ischemia.

Sheth KN.

Stroke. 2013 Jun;44(6 Suppl 1):S136. doi: 10.1161/STROKEAHA.113.001821. No abstract available.

8.

Influence of glibenclamide on outcome in patients with type 2 diabetes and traumatic brain injury.

Ding J, Yuan F, Guo JY, Chen H, Tian HL.

Clin Neurol Neurosurg. 2013 Oct;115(10):2166-9. doi: 10.1016/j.clineuro.2013.08.010. Epub 2013 Aug 17.

PMID:
23998719
9.

Glyburide is associated with attenuated vasogenic edema in stroke patients.

Kimberly WT, Battey TW, Pham L, Wu O, Yoo AJ, Furie KL, Singhal AB, Elm JJ, Stern BJ, Sheth KN.

Neurocrit Care. 2014 Apr;20(2):193-201. doi: 10.1007/s12028-013-9917-z.

10.

Effect of glibenclamide on the prevention of secondary brain injury following ischemic stroke in humans.

Khanna A, Walcott BP, Kahle KT, Simard JM.

Neurosurg Focus. 2014 Jan;36(1):E11. doi: 10.3171/2013.10.FOCUS13404. Review.

11.

Sulfonylurea Receptor 1 in Humans with Post-Traumatic Brain Contusions.

Martínez-Valverde T, Vidal-Jorge M, Martínez-Saez E, Castro L, Arikan F, Cordero E, Rădoi A, Poca MA, Simard JM, Sahuquillo J.

J Neurotrauma. 2015 Oct 1;32(19):1478-87. doi: 10.1089/neu.2014.3706. Epub 2015 Jun 3.

12.

Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury.

Simard JM, Tsymbalyuk O, Keledjian K, Ivanov A, Ivanova S, Gerzanich V.

Exp Neurol. 2012 Jan;233(1):566-74. doi: 10.1016/j.expneurol.2011.11.044. Epub 2011 Dec 8.

13.

Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury.

Simard JM, Tsymbalyuk O, Ivanov A, Ivanova S, Bhatta S, Geng Z, Woo SK, Gerzanich V.

J Clin Invest. 2007 Aug;117(8):2105-13.

14.

Glibenclamide for the treatment of acute CNS injury.

Kurland DB, Tosun C, Pampori A, Karimy JK, Caffes NM, Gerzanich V, Simard JM.

Pharmaceuticals (Basel). 2013 Oct 11;6(10):1287-303. doi: 10.3390/ph6101287.

15.

Glyburide Advantage in Malignant Edema and Stroke (GAMES-RP) Trial: Rationale and Design.

Sheth KN, Elm JJ, Beslow LA, Sze GK, Kimberly WT.

Neurocrit Care. 2016 Feb;24(1):132-9. doi: 10.1007/s12028-015-0189-7.

PMID:
26268138
16.

KATP channel subunits in rat dorsal root ganglia: alterations by painful axotomy.

Zoga V, Kawano T, Liang MY, Bienengraeber M, Weihrauch D, McCallum B, Gemes G, Hogan Q, Sarantopoulos C.

Mol Pain. 2010 Jan 26;6:6. doi: 10.1186/1744-8069-6-6.

17.

Glibenclamide improves neurological function in neonatal hypoxia-ischemia in rats.

Zhou Y, Fathali N, Lekic T, Tang J, Zhang JH.

Brain Res. 2009 May 13;1270:131-9. doi: 10.1016/j.brainres.2009.03.010. Epub 2009 Mar 21.

PMID:
19306849
18.

Tumor-associated edema in brain cancer patients: pathogenesis and management.

Roth P, Regli L, Tonder M, Weller M.

Expert Rev Anticancer Ther. 2013 Nov;13(11):1319-25. doi: 10.1586/14737140.2013.852473. Epub 2013 Oct 23. Review.

PMID:
24152171
19.

Relation between macrophage infiltrates and peritumoral edema.

Shinonaga M, Chang CC, Kuwabara T.

Adv Neurol. 1990;52:475-81.

PMID:
2396541
20.

Sequential activation of hypoxia-inducible factor 1 and specificity protein 1 is required for hypoxia-induced transcriptional stimulation of Abcc8.

Woo SK, Kwon MS, Geng Z, Chen Z, Ivanov A, Bhatta S, Gerzanich V, Simard JM.

J Cereb Blood Flow Metab. 2012 Mar;32(3):525-36. doi: 10.1038/jcbfm.2011.159. Epub 2011 Nov 16.

Supplemental Content

Support Center